No Data
Moutai liquor production cuts? Individuals close to Kweichow Moutai: last year's production remained within a normal and orderly Range | Quick read announcement.
In 2024, Kweichow Moutai plans to produce approximately 0.0563 million tons of Moutai liquor, a decrease of 1.58% year-on-year. Last year, increased marketing investments in the Moutai series of liquors and the higher proportion led to a decline in the company's overall net margin, which may have fallen below 50% last year, reaching the lowest level since 2018. Amid soft stock prices, Kweichow Moutai officially initiated a buyback, with nearly 0.3 billion yuan repurchased on the first day.
The competition is fierce! Musk once said that "Tirzepatide", which is more effective than semaglutide, will be launched in China. Who will dominate the weight loss drug market in 2025?
① Today, Eli Lilly and Co announced the official launch of tirzepatide in China, covering both type 2 diabetes and weight loss, and it is already available on some online platforms; ② Musk has claimed that tirzepatide is better than semaglutide, while the market is more focused on the pricing of tirzepatide and whether it will be included in medical insurance; ③ The competition in the GLP-1 sector will become even more intense in 2025, with Jiangsu Hengrui Pharmaceuticals, INNOVENT BIO, and Gan & Lee Pharmaceuticals receiving widespread attention.
The "price war" fires the first shot of the new year! Ideal and NIO promote "subsidy guarantees", with over 9 major manufacturers updating car purchase rights.
① Li Auto launched a "replacement subsidy" guarantee, offering a cash subsidy of 15,000 yuan for each vehicle. ② Xpeng Motors has begun a limited-time Spring Festival gift distribution event, including a 0.01 million yuan cash red envelope and an 888-degree electricity card, among others. ③ Although the national policies related to 2025 have not yet been clearly defined, many regions have already introduced local subsidy measures.
Express News | BYD: Every year there are concerns about the slowing sales growth, but the company is confident for 2025.
So sudden! What happened with the well-known Hong Kong stocks in a collective turmoil?
In today's morning session, the Hong Kong stock market suddenly experienced a significant decline, with all three major Indexes dropping by more than 2%.
Not just a simple "split": The multifaceted considerations behind the sale of WUXI APPTEC's CGT Business.
In an era where Globalization and protectionism coexist, the rapid iteration of cutting-edge technologies, alongside multiple constraints from policies and capital, poses unprecedented challenges for pharmaceutical innovation companies.